Tagging single nucleotide polymorphisms in phosphoinositide-3-kinase- related protein kinase genes involved in DNA damage "checkpoints" and lung cancer susceptibility

Clinical Cancer Research

Volumn 14, Issue 9, 2008, Pages 2887-2891

  Hu, Zhibin ^a   Liu, Hongliang ^b   Wang, Haifeng ^c   Miao, Ruifen ^a   Sun, Weiwei ^c   Jin, Guangfu ^a   Wang, Ying ^d   Hongxia, Ma ^a   Jin, Li ^b   Wei, Qingyi ^f   Lu, Daru ^b   Huang, Wei ^d,e   Shen, Hongbing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Shanghai South Gene Technology Co Ltd

^d CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATR PROTEIN; DNA DEPENDENT PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ENZYME SUBUNIT; FEMALE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; CASE CONTROL STUDY; CHINA; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; LUNG TUMOR; METABOLISM; MIDDLE AGED;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGED; CASE-CONTROL STUDIES; CHINA; DNA DAMAGE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN KINASES;

EID: 52049109867     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1822     Document Type: Article

References (25)

1. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001;411:366-74.
2. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342-8.
3. Friedberg EC, Walker GC, Siede W. DNA repair and mutagenesis. Washington (DC): ASM Press; 1995.
4. Rouse J, Jackson SP. Interfaces between the detection, signaling, and repair of DNA damage. Science 2002;297:547-51.
5. Nyberg KA, Michelson RJ, Putnam CW, Weinert TA. Toward maintaining the genome: DNA damage and replication checkpoints. Annu Rev Genet 2002;36:617-56.
6. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000;408:433-9.
7. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003;3:155-68.
8. Falck J, Coates J, Jackson SP. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 2005;434:605-11.
9. Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 2001;15:2177-96.
10. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995;268:1749-53.
11. Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005;434:864-70.
12. Landi S, Gemignani F, Canzian F, et al. DNA repair and cell cycle control genes and the risk of young-onset lung cancer. Cancer Res 2006;66:11062-9.
13. Kim JH, Kim H, Lee KY, et al. Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk. Hum Mol Genet 2006;15:1181-6.
14. Zienolddiny S, Campa D, Lind H, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006;27:560-7.
15. Fu YP, Yu JC, Cheng TC, et al. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res 2003;63:2440-6.
16. Liu Y Zhang H, Zhou K, et al. Tagging SNPs in nonhomologous end-joining pathway genes and risk of glioma. Carcinogenesis 2007;28:1906-13.
17. Hu Z, Wang H, Shao M, et al. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis. Hum Mutat 2007;28:431-40.
18. Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 2001;276:42462-7.
19. Ward IM, Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem 2001;276:47759-62.
20. Wang B, Matsuoka S, Carpenter PB, Elledge SJ. 53BP1, a mediator of the DNA damage checkpoint. Science 2002;298:1435-8.
21. Stewart GS, Wang B, Bignell CR, Taylor AM, Elledge SJ. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 2003;421:961-6.
22. Celeste A, Petersen S, Romanienko PJ, et al. Genomic instability in mice lacking histone H2AX. Science 2002;296:922-7.
23. Celeste A, Difilippantonio S, Difilippantonio MJ, et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 2003;114:371-83.
24. Stiff T, O'Driscoll M, Rief N, Iwabuchi K, Lobrich M, Jeggo PA. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res 2004;64:2390-6.
25. Hartley KO, Gell D, Smith GC, et al. DNA-dependent protein kinase catalytic subunit: a relative of phospha-tidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 1995;82:849-56.